MAPT and Alzheimer disease: Among them, we can find the quinoline-based fluorescent probes (i.e., Q-tau 1 to 4, Figure 3) reported by Elbatrawy et al. [157], which showed a high selectivity towards Tau aggregates in ex vivo samples from AD brain tissues.